Evaxion - Return on Tangible Equity 2020-2025 | EVAX

Current and historical return on tangible equity values for Evaxion - (EVAX) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Evaxion - Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-06-30 $-0.02B $0.00B -184.00%
2023-06-30 $-0.03B $0.00B -123.46%
2022-06-30 $-0.02B $0.02B -101.05%
2022-03-31 $-0.03B $0.03B -107.22%
2021-12-31 $-0.02B $0.03B -96.97%
2021-09-30 $-0.02B $0.02B -108.11%
2021-06-30 $-0.02B $0.02B -133.33%
2021-03-31 $-0.02B $0.03B -182.86%
2020-12-31 $-0.02B $0.01B -857.14%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.004B $0.003B
Evaxion A/S is a clinical-stage TechBio company specializing in developing AI-Immunology(TM) powered vaccines. Evaxion A/S, formerly known as Evaxion Biotech A/S, is based in COPENHAGEN, Denmark.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.009B 57.26
Doximity (DOCS) United States $11.611B 51.52
Tempus AI (TEM) United States $11.485B 0.00
Hims & Hers Health (HIMS) United States $10.735B 88.82
IRhythm Technologies (IRTC) United States $5.216B 0.00
Hinge Health (HNGE) United States $4.368B 0.00
Privia Health (PRVA) United States $2.542B 188.27
Inspire Medical Systems (INSP) United States $2.482B 36.49
Phreesia (PHR) United States $1.657B 0.00
Enovis (ENOV) United States $1.643B 8.69
10x Genomics (TXG) United States $1.577B 0.00
Omnicell (OMCL) United States $1.449B 27.91
Schrodinger (SDGR) United States $1.383B 0.00
Azenta (AZTA) United States $1.339B 58.42
Clover Health Investments (CLOV) United States $1.272B 0.00
Claritev (CTEV) United States $1.080B 0.00
Evolent Health (EVH) United States $1.033B 0.00
Fulgent Genetics (FLGT) United States $0.643B 0.00
Veradigm (MDRX) United States $0.503B 0.00
Standard BioTools (LAB) United States $0.498B 0.00
Zepp Health (ZEPP) Netherlands $0.496B 0.00
Talkspace (TALK) United States $0.419B 125.00
Carlsmed (CARL) $0.351B 0.00
Butterfly Network (BFLY) United States $0.350B 0.00
TruBridge (TBRG) United States $0.294B 51.53
Nyxoah SA (NYXH) Belgium $0.228B 0.00
Outset Medical (OM) United States $0.225B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.212B 0.00
Health Catalyst (HCAT) United States $0.211B 0.00
KORU Medical Systems (KRMD) United States $0.192B 0.00
CapsoVision (CV) United States $0.188B 0.00
MDxHealth SA (MDXH) Belgium $0.136B 0.00
American Well (AMWL) United States $0.110B 0.00
CareCloud (CCLD) United States $0.107B 4.87
EUDA Health Holdings (EUDA) Singapore $0.096B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.093B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.072B 0.00
Pulmonx (LUNG) United States $0.065B 0.00
111 (YI) China $0.058B 0.00
P3 Health Partners (PIII) United States $0.048B 0.00
HeartBeam (BEAT) United States $0.041B 0.00
Zhongchao (ZCMD) China $0.024B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.021B 0.00
Healthcare Triangle (HCTI) United States $0.018B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.005B 0.00
Movano (MOVE) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
PROFUSA (PFSA) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00